Christopher J. Coughlin - Jan 3, 2023 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Jan 3, 2023
Transactions value $
$107,944
Form type
4
Date filed
1/5/2023, 03:45 PM
Previous filing
Jan 4, 2023
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Award $35.4K +321 $110.41 321 Jan 3, 2023 Common Stock 321 $193.19 Direct F1, F2
transaction KRTX Option (right to buy) Award $45K +407 $110.57 407 Jan 3, 2023 Common Stock 407 $193.19 Direct F1, F2
transaction KRTX Option (right to buy) Award $7.5K +67 $111.94 67 Jan 3, 2023 Common Stock 67 $193.19 Direct F1, F2
transaction KRTX Option (right to buy) Award $20K +181 $110.50 181 Jan 3, 2023 Common Stock 181 $193.19 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees for board services in 2023.
F2 This option vests as to 25% of the shares underlying the option award on each three month anniversary following the vesting commencement date of January 3, 2023.